These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8772539)

  • 1. Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts.
    Thomassen MJ; Antal JM; Barna BP; Divis LT; Meeker DP; Wiedemann HP
    Am J Physiol; 1996 Jan; 270(1 Pt 1):L159-63. PubMed ID: 8772539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages.
    Thomassen MJ; Meeker DP; Antal JM; Connors MJ; Wiedemann HP
    Am J Respir Cell Mol Biol; 1992 Sep; 7(3):257-60. PubMed ID: 1520490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of exosurf (surfactant)-mediated suppression of stimulated human alveolar macrophage cytokine responses.
    Thomassen MJ; Antal JM; Connors MJ; Meeker DP; Wiedemann HP
    Am J Respir Cell Mol Biol; 1994 Apr; 10(4):399-404. PubMed ID: 8136155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
    Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
    Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive properties of surfactant and plasma on alveolar macrophages.
    Allen JN; Moore SA; Pope-Harman AL; Marsh CB; Wewers MD
    J Lab Clin Med; 1995 Mar; 125(3):356-69. PubMed ID: 7897303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.
    Thomassen MJ; Antal JM; Divis LT; Wiedemann HP
    Clin Immunol Immunopathol; 1995 Nov; 77(2):201-5. PubMed ID: 7586728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan production in vitro by fetal lung fibroblasts and epithelial cells exposed to surfactants of N-acetylcysteine.
    Johnsson H; Heldin P; Sedin G; Laurent TC
    Ups J Med Sci; 1997; 102(3):199-209. PubMed ID: 9556844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant inhibits cationic liposome-mediated gene transfer.
    Tsan MF; Tsan GL; White JE
    Hum Gene Ther; 1997 May; 8(7):817-25. PubMed ID: 9143907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiologic response and lung distribution of lavage versus bolus Exosurf in piglets with acute lung injury.
    Balaraman V; Sood SL; Finn KC; Hashiro G; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1838-43. PubMed ID: 8665043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different surfactant preparations on bacterial growth in vitro.
    Neumeister B; Woerndle S; Bartmann P
    Biol Neonate; 1996; 70(2):128-34. PubMed ID: 8864432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of synthetic surfactant Exosurf on gene transfer in mouse lung in vivo.
    Raczka E; Kukowska-Latallo JF; Rymaszewski M; Chen C; Baker JR
    Gene Ther; 1998 Oct; 5(10):1333-9. PubMed ID: 9930338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant.
    Ernst N; Ulrichskötter S; Schmalix WA; Rädler J; Galneder R; Mayer E; Gersting S; Plank C; Reinhardt D; Rosenecker J
    J Gene Med; 1999; 1(5):331-40. PubMed ID: 10738550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
    Corcoran JD; Berggren P; Sun B; Halliday HL; Robertson B; Curstedt T
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F165-9. PubMed ID: 7820710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.
    Rauprich P; Möller O; Walter G; Herting E; Robertson B
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.
    Sehgal SS; Ewing CK; Richards T; Taeusch HW
    J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.